Abstract
Ageno W, Bertu L, Bucherini E, et al; RIDTS study group. Rivaroxaban treatment for six weeks versus three months in patients with symptomatic isolated distal deep vein thrombosis: randomised controlled trial. BMJ. 2022;379:e072623. 36520715.
MeSH terms
-
Anticoagulants / therapeutic use
-
Humans
-
Pulmonary Embolism*
-
Rivaroxaban / therapeutic use
-
Venous Thromboembolism* / chemically induced
-
Venous Thromboembolism* / drug therapy
-
Venous Thrombosis* / drug therapy
Substances
-
Rivaroxaban
-
Anticoagulants